These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21246527)

  • 21. Proposed staging system for gastrointestinal carcinoid tumors.
    Landry CS; McMasters KM; Scoggins CR; Martin RC
    Am Surg; 2008 May; 74(5):418-22. PubMed ID: 18481499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.
    Pape UF; Berndt U; Müller-Nordhorn J; Böhmig M; Roll S; Koch M; Willich SN; Wiedenmann B
    Endocr Relat Cancer; 2008 Dec; 15(4):1083-97. PubMed ID: 18603570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
    Niederle MB; Hackl M; Kaserer K; Niederle B
    Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroenteric neuroendocrine neoplasms classification: comparison of prognostic models.
    Dolcetta-Capuzzo A; Villa V; Albarello L; Franchi GM; Gemma M; Scavini M; Di Palo S; Orsenigo E; Bosi E; Doglioni C; Manzoni MF
    Cancer; 2013 Jan; 119(1):36-44. PubMed ID: 22744914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
    Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
    Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors.
    Kim MK; Warner RR; Roayaie S; Harpaz N; Ward SC; Itzkowitz S; Wisnivesky JP
    J Clin Oncol; 2013 Oct; 31(30):3776-81. PubMed ID: 24043726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
    Hellman P; Lundström T; Ohrvall U; Eriksson B; Skogseid B; Oberg K; Tiensuu Janson E; Akerström G
    World J Surg; 2002 Aug; 26(8):991-7. PubMed ID: 12016480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
    Bahra M; Jacob D; Pascher A; Plockinger U; Kristiansen G; Neuhaus P; Langrehr JM
    J Gastroenterol Hepatol; 2007 Jun; 22(6):930-5. PubMed ID: 17489964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis on clinical characteristics of rectal neuroendocrine tumors].
    Wang HB; Wang LP
    Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(24):1686-9. PubMed ID: 20979878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs).
    Tellez MR; Mamikunian G; O'Dorisio TM; Vinik AI; Woltering EA
    Pancreas; 2013 Apr; 42(3):405-10. PubMed ID: 23160483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.
    Pavel M; Baudin E; Couvelard A; Krenning E; Öberg K; Steinmüller T; Anlauf M; Wiedenmann B; Salazar R;
    Neuroendocrinology; 2012; 95(2):157-76. PubMed ID: 22262022
    [No Abstract]   [Full Text] [Related]  

  • 32. DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors.
    Rahman MM; Qian ZR; Wang EL; Yoshimoto K; Nakasono M; Sultana R; Yoshida T; Hayashi T; Haba R; Ishida M; Okabe H; Sano T
    Hum Pathol; 2010 Aug; 41(8):1069-78. PubMed ID: 20381114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma.
    Nozaki Y; Yamamoto M; Ikai I; Yamamoto Y; Ozaki N; Fujii H; Nagahori K; Matsumoto Y; Yamaoka Y
    Cancer; 1998 Nov; 83(9):1923-9. PubMed ID: 9806650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Chinese classification system compared with TNM staging in prognosis of patients with primary hepatic carcinoma after resection.
    Sheng JM; Zhao WH; Wu FS; Ma ZM; Feng YZ; Zhou XR; Teng LS
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):561-4. PubMed ID: 16286262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin.
    Johanson V; Tisell LE; Olbe L; Wängberg B; Nilsson O; Ahlman H
    Br J Cancer; 1999 Jun; 80(8):1259-61. PubMed ID: 10376980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroenteropancreatic neuroendocrine neoplasms: historical context and current issues.
    Yang Z; Tang LH; Klimstra DS
    Semin Diagn Pathol; 2013 Aug; 30(3):186-96. PubMed ID: 24144288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.
    Modlin IM; Gustafsson BI; Pavel M; Svejda B; Lawrence B; Kidd M
    Neuroendocrinology; 2010; 92(3):143-57. PubMed ID: 20733279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland.
    Cwikla JB; Nasierowska-Guttmejer A; Jeziorski KG; Cichocki A; Zgliczynski W; Stepień K; Seklecka N; Durlik M; Malkowski B; Walecki J
    Neuro Endocrinol Lett; 2007 Dec; 28(6):789-800. PubMed ID: 18063942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital.
    Rothenstein J; Cleary SP; Pond GR; Dale D; Gallinger S; Moore MJ; Brierley J; Siu LL
    Am J Clin Oncol; 2008 Feb; 31(1):64-70. PubMed ID: 18376230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.
    Strosberg J; Nasir A; Coppola D; Wick M; Kvols L
    Hum Pathol; 2009 Sep; 40(9):1262-8. PubMed ID: 19368957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.